Furthermore, of the 328 pancreatic tumors included in the cBioPortal database (Bailey et al., 2018; Gao et al., 2013; Jiao et al., 2014; Scarpa et al., 2017; Wu et al., 2011) only 12 (3.7%) harbored CTNNB1 exon 3 mutations (Fig. 1C). This evidence concerns the gene CTNNB1 and pancreatic neoplasm.